Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03385330 · ClinicalTrials.gov registry record · NA
BPD Saturation TARgeting
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03385330 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 50 participants.
The verdict
NCT03385330, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Bronchopulmonary dysplasia (BPD), or chronic lung disease of prematurity, affects nearly half of extremely preterm infants.This study evaluates the use of supplemental oxygen to manage infants with established BPD. Participants will be randomly placed in either a higher oxygen saturation group or a lower oxygen saturation target group.
Interventions
- OTHER LOWER oxygen saturation target group
- OTHER HIGHER oxygen saturation target group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2023-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03385330
The ClinicalTrials.gov registry entry for NCT03385330 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LOWER oxygen saturation target group is the first listed.
NCT03385330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03385330 about?
NCT03385330 is a clinical study titled "BPD Saturation TARgeting". Bronchopulmonary dysplasia (BPD), or chronic lung disease of prematurity, affects nearly half of extremely preterm infants.This study evaluates the use of supplemental oxygen to manage infants with established BPD. Participants will be randomly placed in either a higher oxygen saturation group or a ...
What is the current status of trial NCT03385330?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-06-01. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT03385330?
The interventions under investigation include: LOWER oxygen saturation target group (OTHER), HIGHER oxygen saturation target group (OTHER).
Who is sponsoring clinical trial NCT03385330?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.